▪ Accumulation of/inability to clear secretions

▪ Progressive destruction of the normal lung architecture

Clinical manifestations:

▪ Chronic cough, green/yellow sputum, dyspnea

▪ Breath indicative of active infection

▪ Crepitation/crackles base of the lung

Complications:

▪ Emphysema

▪ Secondary amyloidosis

Emphysema

▪ Permanent enlargement of alveoli accompanied by destruction of alveolar walls without

obvious fibrosis

Etiology:

▪ COPD (main reason)

Pathophysiology:

▪ Loss of elastic recoil

▪ Dilation and combining air spaces reduces surface area for oxygen exchange

▪ Ruptured alevoli

Clinical manifestations

▪ As in other COPD

▪ Labored breathing

▪ Barrel chest

*Respiratory Tract Infections

Pneumonia:

▪ Discussed in detail in LUSL2036

▪ Pathophysiology:

– Acute inflammation; accumulation of neutrophils & macrophages, inflammatory mediators, congestion, exudate release, etc.

– Consolidation (inflamed, thickened and scarred airway)

Tuberculosis

▪ Discussed in detail in LUSL2036

▪ Pathophysiology:

– Chronic inflammation, tubercle formation, caseous necrosis

Acute bronchitis

▪ Acute inflammation of the bronchi

▪ Commonly follows a viral infection of upper resp tract

▪ Similar symptoms to pneumonia but does not demonstrate pulmonary consolidation and chest infiltrates

Obstructive Sleep Apnea

▪ Partial or complete upper airway obstruction during sleep

Etiology:

▪ Adenotonsillar hypertrophy is the most common cause.

▪ Pharyngeal web = hyperplasia tissue that blocks the nasopharynx.

▪ At night the nasopharynx relaxes → high CO2 so patient wakens abruptly to temporarily correct breathing pattern (fix apnea).

Pathophysiology:

▪ Mild, moderate, severe based on AHI (apnea-hypopnea index)

▪ Disruption of normal ventilation and sleep patterns

▪ Oxidative stress

– The cells get tired. The endothelium releases NO to dilate the vessels to help with O2

▪ Hypercoagulability and CV complications

Clinical Manifestations and Diagnosis:

▪ Snoring and labored breathing during sleep

▪ Daytime sleepiness

▪ Chronic mouth breathing

▪ Sleep studies (Polysomnography)

▪ Sleep questionnaires:

– Berlin and *STOP-Bang

Pulmonary Vascular Disorders

Pulmonary Embolism (PE)

▪ Occlusion within pulmonary vascular bed by clot (thrombus, embolus), fat/air bubble, amniotic fluid droplet

Etiology and Pathophysiology:

▪ Deep vein thrombosis (DVT) in the lower limb

▪ Virchow triad

▪ Hypoxemia, low oxygen saturation

▪ Perfusion is affected, not ventilation

Clinical manifestations and evaluation:

▪ Dyspnea, chest pain on inspiration

▪ Tachycardia, cyanosis, hypotension

Lab and radiology:

▪ Elevated D-dimer

▪ CT & pulmonary angiography

▪ Doppler US

Pulmonary Hypertension

▪ Elevation of pressure in pulmonary vasculature

▪ Pressure > 20 mm or elevation by 5-10 mm Hg above normal

Etiology & classifications:

▪ Primary pulmonary hypertension (Idiopathic)

▪ Pulmonary hypertension due to left heart disease

– E.g. mitral valve

▪ Pulmonary hypertension due to lung disease/hypoxia

– E.g. COPD

▪ Pulmonary hypertension due thrombo-embolic disease

– E.g. lung clots

Clinical manifestations:

▪ Dyspnea

▪ Fatigue

▪ Dizziness

Complications:

▪ RT ventricular failure

▪ Cor Pulmonale:

– RV enlargement/failure secondary to pulmonary hypertension

Malignancies of the Respiratory Tract

Lung (bronchogenic) cancer

Etiology & risk factors:

▪ Cigarette smoking: most common cause (heavy smokers 20 x > risk than nonsmokers)

▪ Environmental or occupational risk factors e.g. asbestos, radon

Types:

▪ Non-small cell carcinoma:

– Squamous cell carcinoma

– Adenocarcinoma

– Large cell carcinoma

▪ Small cell carcinomas:

– Highly malignant

– Can arise outside lungs (prostate, cervix, LN)

– Can be hormone secreting (paraneoplastic)

Selected Pulmonary Function Disorders in Children – Chapter 27

Cystic Fibrosis

Etiology & Pathophysiology:

▪ Autosomal recessive- mutations in transmembrane conductance regulator (CFTR) gene

– Damages the chloride channels that helps make the mucus, this reduces the water, so the mucus is now thick

▪ Multisystem disease

▪ Exocrine or mucus-producing glands secrete abnormally thick mucus

▪ In the lungs, thick secretions obstruct the bronchioles and predispose to chronic lung infections

▪ Chronic inflammation leads to hyperplasia of goblet cells, bronchiectasis, pneumonia, hypoxia, fibrosis, etc.

Upper Airway Obstruction with Croup

▪ Croup:

– URT infection causing barking like cough

▪ One cause of stridor (noisy breathing) (others are fb.)

▪ Acute laryngotracheobronchitis:

– Children from 6 months to 5 years

– Commonly caused by a virus (influenza, or RSV)

– Usually occurs after an episode of rhinorrhea, sore throat, low-grade fever

– URT inflammation → obstruction → stridor (~70% narrowing)

– Life-threatening

*Acute Epiglottitis

▪ Severe, rapidly progressive, life-threatening infection of the epiglottis and surrounding area

▪ Historically caused by Haemophilus influenzae type B

– 80%-90% decreased incidence due to HIB vaccination

Manifestations:

▪ High fever

▪ Irritability

▪ Sore throat

▪ Inspiratory stridor/ muffled voice

▪ Severe respiratory distress

Aspiration Disorders

Etiology and pathophysiology:

▪ Aspiration of foreign bodies

– In children, ages of 1-3

– Any foreign substance: food, meconium (neonates), secretions (salivary or gastric), or environmental

– Inflammation of the lung tissue (aspiration pneumonitis)

▪ Lung damage depends on volume and pH of aspirate

▪ Leading cause of death in children specially, neurologically compromised

Clinical Manifestations:

▪ Coughing

▪ Choking

▪ Gagging

▪ Wheezing

▪ Symptoms depend on size/ nature of the foreign body

Respiratory distress syndrome (RDS) of newborn

Etiology & Pathophysiology:

▪ Prematurity & lack of adequate surfactant

▪ Primarily a disease of preterm infants

▪ Widespread atelectasis, respiratory distress, and pulmonary hypertension

Clinical manifestations:

▪ Tachypnea

▪ Expiratory grunting

▪ Nasal flaring

▪ Dusky skin

End of Module